BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 30624575)

  • 1. Assessment of Diagnostic Strategy for Early Recognition of Bullous and Nonbullous Variants of Pemphigoid.
    Meijer JM; Diercks GFH; de Lang EWG; Pas HH; Jonkman MF
    JAMA Dermatol; 2019 Feb; 155(2):158-165. PubMed ID: 30624575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of direct and indirect immunofluorescence and of bullous pemphigoid 180 and 230 enzyme-linked immunosorbent assays for diagnosis of bullous pemphigoid.
    Sárdy M; Kostaki D; Varga R; Peris K; Ruzicka T
    J Am Acad Dermatol; 2013 Nov; 69(5):748-753. PubMed ID: 23969034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Diagnostic Strategy for Mucous Membrane Pemphigoid.
    Rashid H; Meijer JM; Diercks GFH; Sieben NE; Bolling MC; Pas HH; Horvath B
    JAMA Dermatol; 2021 Jul; 157(7):780-787. PubMed ID: 33909024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normal human skin is superior to monkey oesophagus substrate for detection of circulating BP180-NC16A-specific IgG antibodies in bullous pemphigoid.
    Emtenani S; Yuan H; Lin C; Pan M; Hundt JE; Schmidt E; Komorowski L; Stanley JR; Hammers CM
    Br J Dermatol; 2019 May; 180(5):1099-1106. PubMed ID: 30315657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of BP230 and BP180-NC16a enzyme-linked immunosorbent assays in the initial diagnosis of bullous pemphigoid: a retrospective study of 138 patients.
    Charneux J; Lorin J; Vitry F; Antonicelli F; Reguiai Z; Barbe C; Tabary T; Grange F; Bernard P
    Arch Dermatol; 2011 Mar; 147(3):286-91. PubMed ID: 21422334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme-linked immunosorbent assay (ELISA) and indirect immunofluorescence testing in a bullous pemphigoid and pemphigoid gestationis.
    Barnadas MA; Rubiales MV; González MJ; Puig L; García P; Baselga E; Pujol R; Alomar A; Gelpí C
    Int J Dermatol; 2008 Dec; 47(12):1245-9. PubMed ID: 19126009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the combination of BP180-NC16a enzyme-linked immunosorbent assay and BP230 enzyme-linked immunosorbent assay in the diagnosis of bullous pemphigoid.
    Yang B; Wang C; Chen S; Chen X; Lu X; Tian H; Yu M; Zhang D; Shi Z; Zhou G; Zhang F
    Indian J Dermatol Venereol Leprol; 2012; 78(6):722-7. PubMed ID: 23075641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzyme-linked immunosorbent assay in autoimmune blistering diseases: preliminary experience of the Dermatology Department of Cagliari.
    Atzori L; Deidda S; Aste N
    G Ital Dermatol Venereol; 2008 Feb; 143(1):1-8. PubMed ID: 18833046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating bullous pemphigoid autoantibodies in the setting of negative direct immunofluorescence findings for bullous pemphigoid: A single-center retrospective review.
    Wang M; Lehman JS; Camilleri MJ; Drage LA; Wieland CN
    J Am Acad Dermatol; 2019 Aug; 81(2):472-479. PubMed ID: 30928465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of BIOCHIP mosaics in diagnostics of bullous pemphigoid: Evaluation and comparison to conventional multistep procedures.
    Adaszewska A; Kalińska-Bienias A; Jagielski P; Woźniak K; Kowalewski C
    J Cutan Pathol; 2020 Feb; 47(2):121-127. PubMed ID: 31603994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibody Detection for Diagnosis in Direct Immunofluorescence-Negative Mucous Membrane Pemphigoid: Ocular and Other Sites Compared.
    Dart J; Setterfield J; Groves RW; Mee JB; Diercks GFH; Pas HH; Minassian D;
    Ophthalmology; 2021 Mar; 128(3):372-382. PubMed ID: 32745569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of the pattern-based approach using BIOCHIP-indirect immunofluorescence in the evaluation of subepidermal bullous disorders.
    Venkataswamy C; Vinayagam N; Shanmugasundaram S; Rai R
    J Cutan Pathol; 2023 Mar; 50(3):259-265. PubMed ID: 36444506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of Serum Levels of IgE Autoantibodies Against BP180 With Bullous Pemphigoid Disease Activity.
    van Beek N; Lüttmann N; Huebner F; Recke A; Karl I; Schulze FS; Zillikens D; Schmidt E
    JAMA Dermatol; 2017 Jan; 153(1):30-38. PubMed ID: 27829102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and Immunological Profiles of 14 Patients With Bullous Pemphigoid Without IgG Autoantibodies to the BP180 NC16A Domain.
    Nakama K; Koga H; Ishii N; Ohata C; Hashimoto T; Nakama T
    JAMA Dermatol; 2018 Mar; 154(3):347-350. PubMed ID: 29299596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonbullous pemphigoid: Insights in clinical and diagnostic findings, treatment responses, and prognosis.
    Lamberts A; Meijer JM; Pas HH; Diercks GFH; Horváth B; Jonkman MF
    J Am Acad Dermatol; 2019 Aug; 81(2):355-363. PubMed ID: 31009674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A highly sensitive enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid.
    Zillikens D; Mascaro JM; Rose PA; Liu Z; Ewing SM; Caux F; Hoffmann RG; Diaz LA; Giudice GJ
    J Invest Dermatol; 1997 Nov; 109(5):679-83. PubMed ID: 9347799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a BP180-NC16a enzyme-linked immunosorbent assay in the initial diagnosis of bullous pemphigoid.
    Sakuma-Oyama Y; Powell AM; Oyama N; Albert S; Bhogal BS; Black MM
    Br J Dermatol; 2004 Jul; 151(1):126-31. PubMed ID: 15270881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible paraneoplastic syndrome case of bullous pemphigoid with immunoglobulin G anti-BP180 C-terminal domain antibodies associated with psoriasis and primary macroglobulinemia.
    Maki N; Demitsu T; Umemoto N; Nagashima K; Nakamura T; Kakurai M; Nakamura S; Yamada T; Ishii N; Hashimoto T
    J Dermatol; 2016 May; 43(5):571-4. PubMed ID: 26507447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of C3d immunohistochemical staining to enzyme-linked immunosorbent assay and immunofluorescence for diagnosis of bullous pemphigoid.
    Wang LL; Moshiri AS; Novoa R; Simpson CL; Takeshita J; Payne AS; Chu EY
    J Am Acad Dermatol; 2020 Jul; 83(1):172-178. PubMed ID: 32068042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of BP180NC16a-enzyme-linked immunosorbent assay (ELISA) in the diagnosis of bullous pemphigoid in China.
    Feng S; Lin L; Jin P; Wu Q; Zhou W; Sang H; Shao C
    Int J Dermatol; 2008 Jan; 47(1):24-8. PubMed ID: 18173596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.